Terms: = Thyroid cancer AND MDM4, DKFZp781B1423, 4194, ENSG00000198625, RP11-430C7_1, MRP1, MDMX, MGC132766
28261 results:
1. Feasibility and safety of modified en-bloc resection in endoscopic thyroid surgery via bilateral areolar approach - long-term institutional analysis ten years after surgery.
Xie Q; Ma J; Du Y; Liu L; Zhu R; Liu D; Wang P; Yu X
Front Endocrinol (Lausanne); 2024; 15():1302510. PubMed ID: 38694946
[TBL] [Abstract] [Full Text] [Related]
2. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
3. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta-analysis.
Liu X; Wong CKH; Wu T; Chan WWL; Woo YC; Lam CLK; Lang BHH
World J Surg; 2024 Feb; 48(2):393-407. PubMed ID: 38686801
[TBL] [Abstract] [Full Text] [Related]
4. Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium.
Kinet S; Cornette H; Van Den Heede K; Brusselaers N; Van Slycke S
World J Surg; 2024 Feb; 48(2):386-392. PubMed ID: 38686788
[TBL] [Abstract] [Full Text] [Related]
5. A comparison of swallowing related quality of life in patients undergoing transoral endoscopic versus open thyroid surgery.
Deshmukh P; Shiva B; Yadav SK; Agarwal P; Sharma D; Johri G
World J Surg; 2024 Feb; 48(2):379-385. PubMed ID: 38686757
[TBL] [Abstract] [Full Text] [Related]
6. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
[TBL] [Abstract] [Full Text] [Related]
7. Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research.
Zhao J; Liu G; Yang X; Zhang C; Han B; Jiang M
Front Endocrinol (Lausanne); 2024; 15():1253832. PubMed ID: 38686201
[TBL] [Abstract] [Full Text] [Related]
8. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
9. 2022 Fukushima Medical University International Symposium on the Fukushima Health Management Survey Build Back Better, Together. "Science for Society: Advancing Fukushima's Well-Being".
Tsubokura M; Kamiya K
Fukushima J Med Sci; 2024; 70(2):103-106. PubMed ID: 38684412
[TBL] [Abstract] [Full Text] [Related]
10. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
[TBL] [Abstract] [Full Text] [Related]
11. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
Sang Y; Min R; Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
[TBL] [Abstract] [Full Text] [Related]
12. Biological functions of PCAT-1/ SOX4 in cell proliferation and invasion of breast cancer.
Huang T; Zhang J
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):90-94. PubMed ID: 38678622
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of endoscopic thyroidectomy via the oral vestibule approach and the areola approach for papillary thyroid carcinoma.
Liu Y; Lin F; Yan W; Lin E; Kuang P; Hong X; Lu Y; Wu G; Li L
BMC Surg; 2024 Apr; 24(1):127. PubMed ID: 38678205
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic Value of Immunostaining for thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.
Feier CVI; Vonica RC; Faur AM; Streinu DR; Muntean C
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673931
[TBL] [Abstract] [Full Text] [Related]
16. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of fibrin sealant application in patients undergoing thyroidectomy: a systematic review and meta-analysis.
Zheng X; Wang F; Su YC; Xu CY; Wang MZ
BMC Surg; 2024 Apr; 24(1):122. PubMed ID: 38658932
[TBL] [Abstract] [Full Text] [Related]
18. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
Zhang B; Liu Y; Yu J; Lin X
Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
[TBL] [Abstract] [Full Text] [Related]
19. thyroid US-guided FNA techniques: A prospective,randomized controlled study.
Cohn S; Farhat R; El Khatib N; Asakly M; Khater A; Safia A; Karam M; Massoud S; Bishara T; Avraham Y; Sharabi-Nov A; Merchavy S
Am J Otolaryngol; 2024; 45(1):104091. PubMed ID: 38652678
[TBL] [Abstract] [Full Text] [Related]
20. PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
Kuboki Y; Koyama T; Matsubara N; Naito Y; Kondo S; Harano K; Yonemori K; Yoh K; Gu Y; Mita T; Chen X; Ueda E; Yamamoto N; Doi T; Shimizu T
Cancer Med; 2024 Apr; 13(8):e6980. PubMed ID: 38651187
[TBL] [Abstract] [Full Text] [Related]
[Next]
